- Home
- DSY vs PDSB Comparison
DSY vs PDSB Comparison
Compare DSY & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSY
- PDSB
- Stock Information
- Founded
- DSY 2020
- PDSB 2005
- Country
- DSY China
- PDSB United States
- Employees
- DSY N/A
- PDSB N/A
- Industry
- DSY
- PDSB Biotechnology: Pharmaceutical Preparations
- Sector
- DSY
- PDSB Health Care
- Exchange
- DSY Nasdaq
- PDSB Nasdaq
- Market Cap
- DSY 72.0M
- PDSB 72.2M
- IPO Year
- DSY N/A
- PDSB N/A
- Fundamental
- Price
- DSY $1.05
- PDSB $1.19
- Analyst Decision
- DSY
- PDSB Strong Buy
- Analyst Count
- DSY 0
- PDSB 2
- Target Price
- DSY N/A
- PDSB $10.00
- AVG Volume (30 Days)
- DSY 35.7K
- PDSB 346.9K
- Earning Date
- DSY 01-01-0001
- PDSB 08-13-2025
- Dividend Yield
- DSY N/A
- PDSB N/A
- EPS Growth
- DSY 120.37
- PDSB N/A
- EPS
- DSY 0.01
- PDSB N/A
- Revenue
- DSY $7,323,356.00
- PDSB N/A
- Revenue This Year
- DSY N/A
- PDSB N/A
- Revenue Next Year
- DSY N/A
- PDSB N/A
- P/E Ratio
- DSY $85.22
- PDSB N/A
- Revenue Growth
- DSY 16.37
- PDSB N/A
- 52 Week Low
- DSY $0.95
- PDSB $0.85
- 52 Week High
- DSY $6.98
- PDSB $4.29
- Technical
- Relative Strength Index (RSI)
- DSY 30.92
- PDSB 49.72
- Support Level
- DSY $1.07
- PDSB $1.13
- Resistance Level
- DSY $1.15
- PDSB $1.32
- Average True Range (ATR)
- DSY 0.11
- PDSB 0.08
- MACD
- DSY -0.01
- PDSB 0.02
- Stochastic Oscillator
- DSY 0.00
- PDSB 56.67
About DSY Big Tree Cloud Holdings Limited Ordinary Shares
Big Tree Cloud Holdings Ltd is a consumer-oriented, mission-driven, and technology-empowered company engaged in the development, production, and sales of personal care products and other consumer goods. In particular, it is focused on the development and production of feminine pads and other feminine hygiene products. Through its platform, the company focuses on high-quality product development, deep customer engagement, and efficient sales and marketing.
About PDSB PDS Biotechnology Corporation
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.